APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels
- PMID: 18378515
- PMCID: PMC2900905
- DOI: 10.1093/hmg/ddn101
APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels
Abstract
We characterized 102 kb of chromosome 19 containing the apolipoprotein (APO) E/C1/C4/C2 cluster and two flanking genes for common DNA variants associated with plasma low-density lipoprotein cholesterol (LDL-C) level. DNA variants were identified by comparing sequences of 48 haploid hybrid cell lines. We genotyped participants (1943 Whites and 2046 African-Americans) of the Coronary Artery Risk Development in Young Adults study for 115 variants. After controlling for the effects of the APOE epsilon2/3/4 polymorphism, a single nucleotide polymorphism, rs35136575, in the downstream hepatic control region 2 (HCR-2) was associated with LDL-C in Caucasians (P = 0.0004), accounting for 1% of variation. We genotyped rs35136575 in the Atherosclerosis Risk in Communities (ARIC) cohort (3679 African-Americans and 10 427 Whites) and in the Genetic Epidemiology Network of Arteriopathy (GENOA) sibships (1381 African-Americans in 592 sibships, 1116 Caucasians in 503 sibships and 1378 Mexican-Americans in 416 sibships), finding association with LDL-C level in ARIC Caucasians (P = 0.0064). Lower plasma LDL-C was observed with the rare allele. Plasma apoE level was strongly associated with HCR-2 variant genotype in all three GENOA samples (P </= 0.002), indicating an effect on apoE concentration. Patterns of association for plasma apo A-I, apoB, LDL-C, high-density lipoprotein cholesterol, total cholesterol and triglyceride levels with rs35136575 in the population-based samples evaluated in this study suggest a pleiotropic effect that may be context-dependent.
Figures




References
-
- Eichner J.E., Dunn S.T., Perveen G., Thompson D.M., Stewart K.E., Stroehla B.C. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 2002;155:487–495. - PubMed
-
- Frikke-Schmidt R., Sing C.F., Nordestgaard B.G., Tybjaerg-Hansen A. Gender- and age-specific contributions of additional DNA sequence variation in the 5′ regulatory region of the APOE gene to prediction of measures of lipid metabolism. Hum. Genet. 2004;115:331–345. - PubMed
-
- Song Y., Stampfer M.J., Liu S. Meta-analysis, Apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 2004;141:137–147. - PubMed
-
- Isaacs A., Sayed-Tabatabaei F.A., Aulchenko Y.S., Zillikens M.C., Sijbrands E.J.G., Schut A.F.C., Rutten W.P.F., Pols H.A.P., Witteman J.C.M., Oostra B.A., van Duijn C.M. Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: the Erasmus Rucphen Family Study. Eur. J. Epidemiol. 2007;22:99–105. - PMC - PubMed
-
- Kamboh M.I., Bunker C.H., Aston C.E., Nestlerode C.S., McAllister A.E., Ukoli F.A. Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African Blacks. Genet. Epidemiol. 1999;16:205–222. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous